simAbs

SimAbs – Founded in 2019, simAbs operates from its state-of-the-art labs and offices located in BioVille, Belgium. The company’s core focus lies in the research, development, and GMP manufacturing of antibodies. With a robust patent portfolio centered around its unique continuous manufacturing technology, simAbs is on a mission to redefine bioprocessing. This aims to facilitate cost-effective, high-quality, and sustainable antibody manufacturing.